home / stock / ctx:cc / ctx:cc news

CTX:CC News and Press, Crescita Therapeutics Inc.

Stock Information
Company Name: Crescita Therapeutics Inc.
Stock Symbol: CTX:CC
Market: TSXC
Website: crescitatherapeutics.com
Menu
CTX:CC CTX:CC Quote CTX:CC Short CTX:CC News CTX:CC Articles CTX:CC Message Board
Get CTX:CC Alerts

News, Short Squeeze, Breakout and More Instantly...
CTX:CC - Leading Canadian Healthcare Services Provider Selects Crescita as Exclusive Manufacturing Partner under 5-Year Agreement

Crescita Therapeutics Inc. ( TSX: CTX and OTC US: CRRTF ) (“ Crescita ” or the “ Company ”), a growth-oriented, innovation-driven Canadian commercial dermatology company with in-house R&D and manufacturing capabilities, today announced that it has s...
CTX:CC - Crescita Expands Medical Aesthetic Portfolio with MicronJetTM600 The World's Smallest Intradermal Delivery Device

Crescita Therapeutics Inc. ( TSX: CTX and OTC US: CRRTF ) (“Crescita” or the “Company”), a growth-oriented, innovation-driven Canadian commercial dermatology company, today announced that it has signed an exclusive distribution agreement (the “Agreement&...

CTX:CC - Crescita Completes Acquisition of Strategic Assets of Occy Laboratory

Crescita Therapeutics Inc. ( TSX: CTX and OTC US: CRRTF ) (“Crescita” or the “Company”), a growth-oriented, innovation-driven Canadian commercial dermatology company, today announced that it has concluded the asset purchase agreement (the “Purchase Agree...

CTX:CC - Crescita to Acquire Strategic Assets of Occy Laboratory

Crescita Therapeutics Inc. ( TSX: CTX and OTC US: CRRTF ) (“Crescita” or the “Company”), a growth-oriented, innovation-driven Canadian commercial dermatology company, today announced that it has agreed to acquire all of the non-real estate business assets of Oc...
CTX:CC - Crescita Reports First Quarter 2024 Results

Crescita Therapeutics Inc. ( TSX: CTX and OTC US: CRRTF ) (“Crescita” or the “Company”), a growth-oriented, innovation-driven Canadian commercial dermatology company, today reported its financial results for the first quarter ended March 31, 2024 (“Q1-20...

CTX:CC - Crescita Reports Q4 and Fiscal 2023 Results

Crescita Therapeutics Inc. ( TSX: CTX and OTC US: CRRTF ) (“Crescita” or the “Company”), a growth-oriented, innovation-driven Canadian commercial dermatology company, today reported its financial results for the fourth quarter and fiscal year ended December 31,...

CTX:CC - Crescita Reports Third Quarter 2023 Results

Crescita Therapeutics Inc. ( TSX: CTX and OTC US: CRRTF ) (“ Crescita ” or the “ Company ”), a growth-oriented, innovation-driven Canadian commercial dermatology company, today reported its financial results for the third quarter ended September 30, 202...
CTX:CC - Crescita Therapeutics Announces Approval of Normal Course Issuer Bid

Crescita Therapeutics Inc. (TSX: CTX) (OTC US: CRRTF) (“ Crescita ” or the “ Company ”) announced today that the Toronto Stock Exchange (the “ TSX ”) has approved the Company’s proposed normal course issuer bid (“ NCIB ȁ...

CTX:CC - Crescita Reports Second Quarter 2023 Results

Crescita Therapeutics Inc. ( TSX: CTX and OTC US: CRRTF ) (“ Crescita ” or the “ Company ”), a growth-oriented, innovation-driven Canadian commercial dermatology company, today reported its financial results for the second quarter ended June 30, 2023 (&...

CTX:CC - Croma-Pharma: Launch of topical anaesthetic Pliaglis® in Europe

Croma-Pharma: Launch of topical anaesthetic Pliaglis® in Europe Canada NewsWire VIENNA , June 1, 2023 /CNW/ -- Croma-Pharma, a global player and challenger in the dynamically growing, minimally invasive aesthetics market, announces that it will launch Pliagl...
Next 10